N.O. XT
Natural health product licensed in Canada
- Other names
- Jacked Factory N.O. XT Nitric Oxide Booster, N.O. XT Nitric Oxide Booster, N.O.-XT, N.O.-XT Nitric Oxide Booster
- Licence holder
- Nutra Holdings Inc.
- NPN or DIN-HM
- 80125263
- Status
- Active licence
- Licence date
- 28 June 2023
- Revision date
- 25 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 1.7 mg | Not calculated |
| L-Citrulline Source : L-citrulline | 500 mg | Not calculated |
| L-Arginine Source : Arginine silicate inositol | 66.7 mg | Not calculated |
| L-Glutathione Source : Glutathione | 66.7 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium, Silicate de calcium, L-Leucine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). L-Arginine supports production of nitric oxide, a molecule involved in vasodilation. L-Arginine plays a role in the production of nitric oxide, a factor in vasodilation. L-Citrulline is a precursor to Larginine; a non-essential amino acid that is involved in nitric oxide synthesis, a factor in vasodilation. L-Citrulline supports nitric oxide production, a factor in vasodilation. A source of substrates for nitric oxide production, a vasodilator.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80125263
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.